InMode is a global provider of energy-based, minimally invasive medical treatment solutions in the aesthetics market, developing and commercializing products that utilize proprietary radiofrequency technology to treat face and body contouring, medical aesthetics, and women's wellness applications. The company's customers include plastic surgeons, dermatologists, facial surgeons, and other medical professionals, served through a direct sales force in multiple countries and independent distributors across more than 100 nations. InMode generates revenue primarily from the sale of product platforms and recurring revenues from consumables, extended warranties, and service contracts, and differentiates itself through clinical validation, including over 110 peer-reviewed publications demonstrating product efficacy, as well as comprehensive physician training and practice development support services.